EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy

Alisa Morshneva iD, Olga Gnedina iD, Maria Igotti

PLOS One · 2025

DOI: 10.1371/journal.pone.0333671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Alisa Morshneva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Colonic Neoplasms, Neoplasm Recurrence, Local, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Support Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modeling cancer recurrence and associated conditions such as cancer cell dormancy remains a significant challenge in cancer research. We developed a novel in vitro model based on platinum-resistant tumor cells treated with a platinum drug, in which cells progress through all stages of recurrence within 30–40 days post-exposure. Our results demonstrate that treatment of platinum-resistant colorectal cancer cells with oxaliplatin enriches the population with quiescent, dormant cells arrested in the G0/G1 phase. These cells exhibit increased autophagy, elevated expression of stem cell markers, reduced reactive oxygen species (ROS) levels, and heightened resistance to chemotherapy. A key advantage of our model is the high survival rate of residual cells, enabling the maintenance of a large cell population. This facilitates the application of conventional research techniques that are often limited in other recurrence models due to the small size of residual populations. Overall, this model provides opportunities for a wide range of further research for studying specific recurrence- and dormancy-associated signaling pathways and for identifying novel therapeutic targets for preventing tumor recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmColonic NeoplasmsNeoplasm Recurrence, LocalModels, BiologicalAntineoplastic AgentsOrganoplatinum CompoundsPlatinumHumansOxaliplatinAutophagyCell Line, TumorReactive Oxygen SpeciesNeoplastic Stem Cells

Substanzen

OxaliplatinReactive Oxygen SpeciesAntineoplastic AgentsOrganoplatinum CompoundsPlatinum

Autor:innen und Institutionen

  • Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.

ORCID-Profile: Alisa Morshneva, Olga Gnedina

Förderung

  • Russian Science Support Foundation

Zitieren

APA

Morshneva, A., Gnedina, O., & Igotti, M. (2025). An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy. PLOS One. https://doi.org/10.1371/journal.pone.0333671

Vancouver

Morshneva A, Gnedina O, Igotti M. An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy. PLOS One. 2025. doi:10.1371/journal.pone.0333671

BibTeX
@article{Morshneva2025,
  author = {Morshneva, Alisa and Gnedina, Olga and Igotti, Maria},
  title = {An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0333671}
}
Kostenlos starten →